KANE v. Nagy

CourtDistrict Court, E.D. Michigan
DecidedApril 15, 2021
Docket2:19-cv-12262
StatusUnknown

This text of KANE v. Nagy (KANE v. Nagy) is published on Counsel Stack Legal Research, covering District Court, E.D. Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
KANE v. Nagy, (E.D. Mich. 2021).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

BRIAN DAVID KANE,

Petitioner, Civil Action No. 19-cv-12262

v. HONORABLE MARK A. GOLDSMITH

NOAH NAGY,

Respondent. _________________________________/

OPINION & ORDER GRANTING AN EVIDENTIARY HEARING ON PETITIONER’S TRIAL COUNSEL CLAIM AND HIS RELATED INEFFECTIVE ASSISTANCE OF APPELLATE COUNSEL CLAIM

Petitioner Brian David Kane filed an application for a writ of habeas corpus, pursuant to 28 U.S.C. § 2254, through his attorney Mary A. Owens (Dkt. 1). Petitioner challenges his conviction for possession of at least 450 grams but less than 1,000 grams of oxycodone, Mich. Comp. Laws § 333.7401(2)(a)(ii); possession of at least 50 but less than 450 grams of morphine, Mich. Comp. Laws § 333.7401(2)(a)(iii); possession of at least 50 but less than 450 grams of methadone, Mich. Comp. Laws § 333.7401(2)(a)(iii); possession of less than 50 grams of hydromorphone, Mich. Comp. Laws § 333.7401(2)(a)(iv); and breaking and entering a store with intent to commit a larceny, Mich. Comp. Laws § 750.110(1). See Pet. Br. at PageID.22 (Dkt. 1- 1); Michigan v. Kane, No. 318237, 2015 WL 1542160, at *1 (Apr. 7, 2015 Mich. Ct. App.). As part of his habeas petition, Petitioner alleges he was denied the effective assistance of trial counsel because trial counsel (i) failed to consult with and/or present the testimony of an expert witness, specifically, an expert in pharmacy accountability, who would have been able to testify that the prosecution’s calculations of the amounts of controlled substances stolen from the pharmacy was significantly in error; (ii) failed to consult with and/or present the testimony of an expert in the methodology of accounting for controlled substances; (iii) failed to conduct a competent cross-examination of the prosecution’s expert witnesses to show that the prosecution’s calculations of “weights” were unreliable and that their “bottom line” methodology was an unreliable method to account for the stolen controlled substances, as a result of his failure to

consult with an expert; and (iv) failed to call experts to rebut the testimony of the prosecution’s witnesses concerning their calculation of the amount of controlled substances that were stolen, (v) failed request appointment of an expert at public expense. See Pet. Br. at PageID.45-46.1 He also argues that appellate counsel was ineffective in failing to raise these challenges in Petitioner’s appeal of right and failing to obtain an expert during the appeal. Id. at PageID.74-77. For the reasons that follow, the Court orders an evidentiary hearing on Petitioner’s expert-related ineffective assistance of counsel claims. I. BACKGROUND Petitioner was convicted after a jury trial in the Jackson County Circuit Court. See Kane,

2015 WL 1542160, at *1. The appellate court summarized the background and some of the trial history as follows: This case arose when a pharmacy was broken into after business hours in September 2010. The prosecuting attorney’s theory of the case was that defendant unsuccessfully tried to pry the door open, then broke a window to gain entry, pried open the cabinet that housed the narcotics, and took many bottles of pills from it. Defense counsel conceded that defendant broke into the pharmacy intending to commit a larceny, but suggested that the prosecution would not be able to prove that defendant knowingly took pills of the kinds, or in the quantities, charged. The subject pharmacy’s supervisor of operations testified that the kind and quantities of drugs missing after the break-in were determined by comparing what was left in the

1 In Petitioner’s organizational scheme, these are claims B(1)-(6); the Court categories them into five claims because his claims B(4) and B(5) are difficult to distinguish from one another.

2 narcotics cabinet after the break-in with inventory records indicating what was there before it.

Id. DNA evidence discovered at the pharmacy by investigators established Petitioner’s identity as the person who broke into the pharmacy. Id. at *8. No controlled substances were ever found, either in Petitioner’s possession, or anywhere else. Id. at *4. At trial, the prosecution presented three pharmacists employed at Allegiance Health, where the larceny occurred: Richard Fifelski, who worked at the pharmacy the day before the break-in, Trial Tr. Vol. II at PageID.816 (Dkt. 6-4); Dr. Scott Gindlesberger, site coordinator for the pharmacy, id. at PageID.907; and Dr. Thomas Crampton, director of the pharmacy operations for Allegiance Health in Jackson, Michigan, Trial Tr. Vol. III at PageID.963 (Dkt. 6-5). Gindlesberger and Crampton were also qualified as expert witnesses. See Trial Tr. Vol. II at PageID.909 (Gindlesberger); Trial Tr. Vol. III at PageID.964 (Crampton). After the break-in was discovered just before midnight on September 3, 2010, Allegiance security called Crampton. Trial Tr. Vol. III at PageID.965. The police asked Crampton to provide a summary of the medications that were taken, and he assigned Gindlesberger with the task of compiling an inventory of what controlled substances were stolen and in what amounts. Id. at PageID.967. The principal prosecution proofs, in addition to witness testimony, were People’s Exhibits 36 (Dkt. 1-9) and 37 (Dkt. 1-10). Exhibit 36 constituted a list of the medications allegedly taken in the break-in. Gindlesberger compiled the list. Exhibit 37, prepared by Gindlesberger at the request of the prosecution, constituted his calculations of the “weights” of the missing drugs. The defense introduced Exhibit Q (Dkt. 1-11), which was the bi-annual inventory report prepared to comply with federal drug enforcement requirements.

3 According to Petitioner, trial counsel did not seek disclosure of the prosecution’s expert witnesses under Michigan Rule of Evidence 702, nor did he subpoena the relevant pharmacy documents until several days before trial. Trial counsel did not actually obtain the pharmacy evidence until after trial had begun. The documents obtained by defense counsel were only the C- 2 logs—perpetual inventories of the controlled substances on hand, not the “primary records.”2

Defense counsel actually stated on the record that he was unprepared to cross-examine the prosecution’s two expert witnesses, pharmacists Gindelsberger and Crampton. Trial Tr. Vol. III at PageID.958 (Dkt. 6-5). Petitioner alleges that defense counsel’s cross-examination of Gindelsberger and Crampton was ineffective because he did not obtain the pharmacy documents sufficiently in advance of trial, nor did counsel consult with any expert who could assist counsel in understanding or challenging the prosecution’s case or the testimony provided by expert/fact witnesses Gindlesberger and Crampton. Counsel’s defense was that the C-2 perpetual inventories of the controlled substances on hand contained significant errors, and, therefore, the “weights” of the drugs shown on Exhibit 37 were inaccurate. Petitioner alleges that trial counsel was ineffective

for failing to receive and review the actual pharmacy records until after trial had begun, and for failing to consult or retain an expert to challenge the prosecution’s methodologies of establishing the weights the stolen drugs. As discussed below in the context of the prejudice of this alleged error on Petitioner, inaccuracies in the weights might have resulted in a conviction carrying a maximum 60-year sentence, rather than a conviction carrying a maximum 40-year sentence.

2 These reports are known as the “C-2” logs, because they are the logs for Schedule 2 controlled substances. The distinction is discussed below in the context of later-retained expert John Mudri’s opinion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anthony Aron v. United States
291 F.3d 708 (Eleventh Circuit, 2002)
Brady v. Maryland
373 U.S. 83 (Supreme Court, 1963)
Strickland v. Washington
466 U.S. 668 (Supreme Court, 1984)
Williams v. Taylor
529 U.S. 420 (Supreme Court, 2000)
Edwards v. Carpenter
529 U.S. 446 (Supreme Court, 2000)
Schriro v. Landrigan
550 U.S. 465 (Supreme Court, 2007)
Cone v. Bell
556 U.S. 449 (Supreme Court, 2009)
Guilmette v. Howes
624 F.3d 286 (Sixth Circuit, 2010)
Couch v. Booker
632 F.3d 241 (Sixth Circuit, 2011)
Terry D. Paprocki v. Dale Foltz
869 F.2d 281 (Sixth Circuit, 1989)
Robinson v. Howes
663 F.3d 819 (Sixth Circuit, 2011)
Gerald McKenzie v. David Smith, Warden
326 F.3d 721 (Sixth Circuit, 2003)
Maurice Whiting v. Sherry Burt, Warden
395 F.3d 602 (Sixth Circuit, 2005)
Tyrik McClellan v. Lloyd Rapelje
703 F.3d 344 (Sixth Circuit, 2013)
Reynolds v. Bagley
498 F.3d 549 (Sixth Circuit, 2007)
Leonard v. Michigan
256 F. Supp. 2d 723 (W.D. Michigan, 2003)
Ware v. Harry
636 F. Supp. 2d 574 (E.D. Michigan, 2008)
Reginald Walker v. Bonita Hoffner
534 F. App'x 406 (Sixth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
KANE v. Nagy, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kane-v-nagy-mied-2021.